Specialty Pharmacy

Too little or too much sleep can lead to inflammatory illnesses.

Immunotherapy for lung cancer patients may cause other conditions to become worse.

Top news of the day from across the health care landscape.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.

Top news of the day from across the healthcare landscape.

Vitamin A combined with Gemzar found to reduce proliferation of cancer cells.

Researchers still urge physicians to use caution utilizing light phototherapy for jaundice infants.

Off-label rilpivirine in combination with emtricitabine and tenofovir may help reduce out-of-pocket spending for patients with HIV.

Xilonix is the first monoclonal antibody immunotherapy that targets and neutralizes interleukin-1 alpha.

Transplanting human stem cells into the spinal cord of patients with amyotrophic lateral sclerosis (ALS) shows promise.

Malignant brain tumor cells found to rely on fats for energy and growth.

Radiation therapy with checkpoint inhibitors offers promise for skin cancer therapy.

Top news of the day from across the health care landscape.

System provides images deep within tumor tissue.

Concern persists among physicians who treat HIV-associated lymphoma with stem cell transplants due to the risk of harming the immune system.

Biodegradable polymer nanoparticles to deliver methotrexate may improve rheumatoid arthritis therapy.

The amount of cerebral microbleeds can influence the severity of physical and cognitive outcomes in MS patients.

Olive oil-based emulsion may help boost efficacy of bladder cancer therapy.

Gestational diabetes significantly increases the risk of developing type 2 diabetes within 5-years after giving birth.

Infants can quickly produce novel antibodies that protect against HIV.

The protein GlyRS helps modify proteins that cause cancer growth.

Research may lead to new treatments for ovarian cancer.

Neurodegeneration in Parkinson’s disease occurs from a failing mitochondrion.

Doxorubicin, all-trans retinoic acid, and entinostat significantly reduced triple-negative breast cancer tumors in mice.

Researchers examine how socialization institutes effect the way individuals in low income areas relate to HIV/AIDS after a natural disaster.

Findings improve the ability of providers to monitor the development of melanoma.

Anthrax toxin proteins are able to control tumor growth.

If cancerous tumors have an addiction to a gene, an inhibitor can be administered that can stop cell growth.